The relationship between vitronectin and hepatic insulin resistance in type 2 diabetes mellitus

Endocrine Journal
Yan CaoXiaorong Zhan

Abstract

The World Health Organization (WHO) estimates that approximately 300 million people will suffer from diabetes mellitus by 2025. Type 2 diabetes mellitus (T2DM) is much more prevalent. T2DM comprises approximately 90% of diabetes mellitus cases, and it is caused by a combination of insulin resistance and inadequate compensatory insulin secretory response. In this study, we aimed to compare the plasma vitronectin (VN) levels between patients with T2DM and insulin resistance (IR) and healthy controls. Seventy patients with IR and 70 age- and body mass index (BMI)-matched healthy controls were included in the study. The insulin, Waist-to-Hip Ratio (WHR), C-peptide (CP) and VN levels of all participants were examined. The homeostasis model of assessment for insulin resistence index (HOMA-IR (CP)) formula was used to calculate insulin resistance. The levels of BMI, fasting plasma gluose (FPG), 2-hour postprandial glucose (2hPG), glycated hemoglobins (HbA1c), and HOMA-IR (CP) were significantly elevated in case group compared with controls. VN was found to be significantly decreased in case group. (VN Mean (Std): 8.55 (2.92) versus 12.88 (1.26) ng/mL p < 0.001). Multiple linear regression analysis was performed. This model explained 4...Continue Reading

References

Sep 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·R PytelaE Ruoslahti
Mar 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·D W BarnesM Shaffer
Dec 2, 1994·Science·K Vuori, E Ruoslahti
Oct 1, 1994·Pathology, Research and Practice·S InuzukaK Tanikawa
Jun 4, 1998·Thrombosis Research·K T Preissner, D Seiffert
Jan 3, 2001·The Journal of Clinical Endocrinology and Metabolism·C TörnJ Ostman
Jan 5, 2002·Human Pathology·G K KoukoulisV E Gould
Mar 11, 2004·European Journal of Biochemistry·Emma AnderssonArtur Schmidtchen
May 30, 2006·Matrix Biology : Journal of the International Society for Matrix Biology·Martin MalmstenArtur Schmidtchen
Nov 29, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·S AsadUNKNOWN Diabetes Incidence in Sweden Study Group
Mar 26, 2014·Diabetes & Metabolic Syndrome·Samreen Siddiqui
Mar 29, 2014·BMC Bioinformatics·Brett HansonPaul A Craig
Apr 22, 2015·World Journal of Diabetes·Surapon Tangvarasittichai
Mar 7, 2018·Metabolism: Clinical and Experimental·Sirimon Reutrakul, Eve Van Cauter
Mar 11, 2018·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Yan DuanGuang Wang

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.